A. Sánchez-Méndez, E. de Jesús, J. C. Flores, P. Gómez-Sal
FULL PAPER
CH), 6.42 (d, JH,H = 2.0 Hz, 2 H, o-Ar), 6.48 (t, JH,H = 2.0 Hz,
Preparation of [PdMe(MeCN){Gn-CH(3,5-Me2pz)2}][BArf4] (13–
4
4
1 H, p-Ar), 7.25–7.45 (m, 10 H, Ph) ppm. 13C{1H} NMR (CDCl3): 16): The cationic compounds 13–16 were synthesized by using the
δ = –7.0 (PdMe), 10.8, 11.2 (pz-Me5), 14.1, 15.2 (pz-Me3), 42.7
(CH2), 68.6 (CH), 70.0 (PhCH2O), 102.0 (p-Ar), 106.9, 107.5 (pz-
following general procedure starting from the amounts indicated
below: 1 equiv. of Na[BArf4] was added to a solution of the corre-
C4), 108.1 (o-Ar), 127.4, 128.0, 128.6 (o-, m-, p-Ph), 136.8 (ipso-Ar, sponding precursor [PdClMe{Gn-CH(3,5-Me2pz)2}] (9–12) in
ipso-Ph), 139.0, 140.8 (pz-C5), 152.1, 152.2 (pz-C3), 160.0 (m-Ar) CH2Cl2 (25 mL) in the presence of an excess of CH3CN. The solu-
ppm. IR (KBr): ν = 1561 (s, C=N), 1595, 1450 (vs, C=C), 1154,
tion was stirred at room temp. for 1 h and the NaCl precipitate
removed by filtration. The solvent was evaporated under reduced
pressure and the crude solid washed with pentane (2ϫ15 mL).
Compounds 13–16 were isolated as orange solids, which are insolu-
ble in alkanes and diethyl ether, although the third-generation com-
pound is slightly soluble, and soluble in toluene and chlorinated
solvents. As corresponds to a noncoordinating anion, identical
spectroscopic data were obtained for the [BArf4]– ion for all four
compounds. These data are as follows and will not be reproduced
˜
1047 (vs, C–O–C) cm–1. MS (APCI in CH2Cl2 + MeOH/H2O, 3:1):
m/z = 680 [M – Me + MeOH]+, 507 [M – PdClMe + H]+, 411 [M –
PdClMe – Me2pz]+.
[PdClMe{G2-CH(3,5-Me2pz)2}] (11): G2-CH(3,5-Me2pz)2 (III;
171 mg, 0.18 mmol), [PdClMe(cod)] (49 mg, 0.18 mmol). Yield:
270 mg (90%). C61H61ClN4O6Pd (1088.05): calcd. C 67.34, H 5.65,
N 5.15; found C 66.84, H 5.50, N 5.17. 1H NMR (CDCl3): δ =
1.00 (s, 3 H, PdMe), 1.93 (s, 3 H, pz-Me5) 1.97 (s, 3 H, pz-Me5),
2.33 (s, 3 H, pz-Me3 adjacent to PdMe), 2.45 (s, 3 H, pz-Me3 adja-
1
later. H NMR (CDCl3): δ = 7.49 (br. s, 4 H, Arf-Hp), 7.68 (br. s,
Arf-Ho) ppm. 13C{1H} NMR (CDCl3): δ = 117.4 (Arf-Cp), 124.4
(q, JC,F = 272.1 Hz, CF3), 129.0 (q, 2JC,F = 29.0 Hz, Arf-Cm), 134.7
2
cent to PdCl), 4.82 (A part of an AB system, JH,H = 12.3 Hz, 2
H, ArCH2O), 4.90 (B part of an AB system, 2JH,H = 12.3 Hz, 2 H,
(Arf-Co), 161.6 (q, JC,B = 50.7 Hz, Arf-Cipso) ppm. IR (KBr): ν =
˜
2
3
ArCH2O), 5.01 (s, 8 H, PhCH2O), 5.08 (dd, JH,H = 13.4, JH,H
=
1357 (s), 1279 (vs), 1128 (vs, B–C, C–F) cm–1.
2
3
7.3 Hz, 1 H, CH2), 5.38 (dd, JH,H = 13.4, JH,H = 8.3 Hz, 1 H,
CH2), 5.67 (s, 1 H, pz-H4), 5.78 (s, 1 H, pz-H4), 5.99 (dd, JH,H
=
3
[PdMe(MeCN){G0-CH(3,5-Me2pz)2}][BArf4] (13): Compound
9
3
4
7.3, JH,H = 8.3 Hz, 1 H, CH), 6.40 (d, JH,H = 1.8 Hz, 2 H, G0-
o-Ar), 6.45 (t, JH,H = 1.8 Hz, 1 H, G0-p-Ar), 6.55 (t, JH,H
(51 mg, 0.11 mmol), Na[BArf4] (101 mg, 0.11 mmol), and CH3CN
(2 mL). Yield: 136 mg (94%). C53H40BF24N5Pd (1320.1): calcd. C
48.22, H 3.05, N 5.30; found C 47.84, H 2.97, N 5.12. 1H NMR
(CDCl3): δ = 1.08 (s, 3 H, PdMe), 1.89 (s, 3 H, pz-Me5) 1.98 (s, 3
H, pz-Me5), 2.18 (s, 3 H, pz-Me3 adjacent to Pd-NCMe), 2.28 (s,
3 H, MeCN), 2.30 (s, 3 H, pz-Me3 adjacent to PdMe), 4.50 (dd,
4
4
=
4
2.2 Hz, 2 H, G1-p-Ar), 6.62 (d, JH,H = 2.2 Hz, 4 H, G1-o-Ar),
7.25–7.45 (m, 20 H, Ph) ppm. 13C{1H} NMR (CDCl3): δ = –7.0
(PdMe), 10.7, 11.1 (pz-Me5), 14.1, 15.1 (pz-Me3), 42.7 (CH2), 68.6
(CH), 69.8 (ArCH2O), 70.0 (PhCH2O), 101.4 (G1-p-Ar), 101.9
(G0-p-Ar), 106.3 (G1-o-Ar), 106.9 (pz-C4), 107.4 (pz-C4), 108.1
(G0-o-Ar), 127.6, 128.0, 128.6 (o-, m-, p-Ph), 134.8 (G0-ipso-Ar),
136.7 (ipso-Ph), 139.3 (G1-ipso-Ar), 139.0, 140.8 (pz-C5), 152.1,
152.2 (pz-C3), 159.9 (G0-m-Ar), 160.2 (G1-m-Ar) ppm. IR (KBr):
3
2
2JH,H = 14.0, JH,H = 6.5 Hz, 1 H, CH2), 5.16 (dd, JH,H = 14.0,
3JH,H = 8.8 Hz, 1 H, CH2), 5.76 (s, 1 H, pz-H4), 5.86 (s, 1 H, pz-
3
3
H4), 6.04 (dd, JH,H = 6.5, JH,H = 8.8 Hz, 1 H, CH), 6.9 (m, 2 H,
Ph), 7.2 (m, 3 H, Ph) ppm. 13C{1H} NMR (CDCl3): δ = –3.6
(PdMe), 3.0 (CH3CN), 10.5, 10.9 (pz-Me5), 13.5, 15.1 (pz-Me3),
42.9 (CH2), 68.9 (CH), 107.3, 108.3 (pz-C4), 121.3 (MeCN), 128.5,
128.7, 129.3 (o-, m-, p-Ph), 133.3 (ipso-Ph), 140.9, 142.6 (pz-C5),
ν = 1560 (s, C=N), 1596, 1451 (vs, C=C), 1154, 1046 (vs, C–O–C)
˜
cm–1. MS (APCI in CH2Cl2 + MeOH/H2O, 3:1): m/z = 1104 [M –
Me + MeOH]+, 931 [M – PdClMe + H]+, 835 [M – PdClMe –
Me2pz]+.
151.1, 153.3 (pz-C3) ppm. IR (KBr): ν = 1611 (m, C=C), 1568 (m,
˜
C=N), 1465 (m, C=C) cm–1. MS (ESI+-TOF in CH2Cl2/MeOH/
NH4HCOO 5 m): m/z = 457.12 [M – BArf4]+, 446.09 [M – CH4 –
MeCN – BArf4 + HCOO]+, 416.11 [M – MeCN – BArf4]+, 400.08
[M – CH4 – MeCN – BArf4]+, 294.39 [M – PdMe(MeCN) –
BArf4]+, 199.28 [M – PdMe(MeCN) – BArf4 – Me2pz]+.
[PdClMe{G3-CH(3,5-Me2pz)2}] (12): G3-CH(3,5-Me2pz)2 (IV;
276 mg, 0.15 mmol) and [PdClMe(cod)] (41 mg, 0.15 mmol). Yield:
255 mg (88%). C117H109ClN4O14Pd (1937.04): calcd. C 72.55, H
1
5.67, N 2.89; found C 72.14, H 5.42, N 2.46. H NMR (CDCl3): δ
= 1.00 (s, 3 H, PdMe), 1.93 (s, 3 H, pz-Me5) 1.94 (s, 3 H, pz-Me5),
2.32 (s, 3 H, pz-Me3 adjacent to PdMe), 2.45 (s, 3 H, pz-Me3 adja-
2
cent to PdCl), 4.81 (A part of an AB system, JH,H = 12.2 Hz, 2 [PdMe(MeCN){G1-CH(3,5-Me2pz)2}][BArf4] (14): Compound 10
2
H, G1-ArCH2O), 4.88 (B part of an AB system, JH,H = 12.3 Hz,
2 H, G1-ArCH2O), 4.94 (s, 8 H, G2-ArCH2O), 5.00 (s, 16 H,
PhCH2O), 5.22 (br. m, 1 H, CH2), 5.65 (s, 1 H, pz-H4), 5.77 (s, 1
(91 mg, 0.14 mmol), Na[BArf4] (121 mg, 0.14 mmol), and CH3CN
(2 mL). Yield: 163 mg (76%). C67H52BF24N5O2Pd (1532.4): calcd.
1
C 52.52, H 3.42, N 4.57; found C 52.35, H 3.45, N 4.62. H NMR
H, pz-H4), 5.98 (br. t, JH,H ≈ 8.0 Hz, 1 H, CH), 6.41 (d, JH,H
=
(CDCl3): δ = 1.03 (s, 3 H, PdMe), 1.83 (s, 3 H, pz-Me5) 1.98 (s, 3
H, pz-Me5), 2.14 (s, 3 H, pz-Me3 adjacent to Pd-NCMe), 2.23 (s,
3 H, MeCN), 2.27 (s, 3 H, pz-Me3 adjacent to PdMe), 4.26 (dd,
3
4
2.0 Hz, 2 H, G0-o-Ar), 6.47 (t, 4JH,H = 2.0 Hz, 1 H, G0-p-Ar), 6.50
4
4
(t, JH,H = 2.0 Hz, 2 H, G1-p-Ar), 6.55 (t, JH,H = 2.2 Hz, 4 H,
4
3
G2-p-Ar), 6.60 (d, 4JH,H = 2.0 Hz, 4 H, G1-o-Ar), 6.65 (d, JH,H
=
2JH,H = 13.5, JH,H = 6.2 Hz, 1 H, CH2), 4.95 (s, 4 H, PhCH2O),
2.2 Hz, 8 H, G2-o-Ar), 7.25–7.40 (m, 40 H, Ph) ppm. 13C{1H} 5.16 (dd, 2JH,H = 13.5, 3JH,H = 9.1 Hz, 1 H, CH2), 5.75 (s, 1 H, pz-
3
3
NMR (CD Cl3): δ = –7.0 (PdMe), 10.7, 11.1 (pz-Me5), 14.1, 15.1
H4), 5.83 (s, 1 H, pz-H4), 5.96 (dd, JH,H = 6.2, JH,H = 9.1 Hz, 1
(pz-Me3), 42.6 (CH2), 68.5 (CH), 69.8 (G1-ArCH2O), 70.0 (G2-
H, CH), 6.17 (d, 4JH,H = 2.1 Hz, 2 H, o-Ar), 6.56 (t, 4JH,H = 2.1 Hz,
ArCH2O), 70.1 (PhCH2O), 101.3 (G1-p-Ar), 101.5, (G2-p-Ar), 1 H, p-Ar), 7.25–7.40 (m, 10 H, Ph) ppm. 13C{1H} NMR (CDCl3):
101.8 (G0-p-Ar), 106.3 (G1-o-Ar), 106.4 (G2-o-Ar), 106.8, 107.4
δ = –3.6 (PdMe), 2.9 (CH3CN), 10.6, 11.0 (pz-Me5), 13.5, 15.1 (pz-
(pz-C4), 108.0 (G0-o-Ar), 127.5, 128.0, 128.6 (o-, m-, p-Ph), 136.7 Me3), 43.1 (CH2), 68.6 (CH), 70.0 (PhCH2O), 101.6 (p-Ar), 107.3,
(G0-ipso-Ar, ipso-Ph), 139.1 (G2-ipso-Ar), 139.2 (G1-ipso-Ar),
108.2 (pz-C4), 108.1 (o-Ar), 121.3 (MeCN), 127.3, 128.2, 128.7
139.0, 140.8 (pz-C5), 152.0, 152.1 (pz-C3), 159.9 (G0-m-Ar), 160.0 (o-, m-, p-Ph), 135.5 (ipso-Ar), 136.3 (ipso-Ph), 140.7, 142.7 (pz-
(G1-m-Ar), 160.1 (G2-m-Ar) ppm. IR (KBr): ν = 1560 (m, C=N), C5), 151.1, 153.2 (pz-C3), 160.4 (m-Ar) ppm. IR (KBr): ν = 1609
˜
˜
1596, 1451 (vs, C=C), 1154, 1048 (vs, C–O–C) cm–1. MS (ESI+-
(m, C=C), 1564 (m, C=N), 1466 (m, C=C), 1154, 1048 (s, C–O–C)
TOF in CH2Cl2/MeOH): m/z = 1939.66 [M – Cl + K]+, 1917.70 cm–1. MS (ESI+-TOF in CH2Cl2/MeOH/NH4HCOO 5 m): m/z =
[M – Me – Cl + MeOH]+, 1900.70 [M –Cl]+, 1884.67 [M – Cl – 669.22 [M – BArf4]+, 627.28 [M – MeCN – BArf4]+, 612.17 [M –
CH4]+, 1802.77 [M – PdClMe + Na + H]+, 1762.74 [M – PdClMe –
CH4 – MeCN – BArf4]+, 411.21 [M – PdMe(MeCN) – BArf4
–
CH4]+.
Me2pz]+.
148
www.eurjic.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Inorg. Chem. 2010, 141–151